查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1338938

超级崩解剂市场、份额、规模、趋势、行业分析报告：按产品；按剂型；按治疗领域；按地区；细分市场预测，2023-2032

Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球超级崩解剂市场规模预计将达到8.2954亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

心血管疾病、糖尿病和癌症等慢性疾病的盛行率不断上升，增加了对药物的需求。 超级崩解剂在这些药物的配方中发挥重要作用，并已成为製药业的重要成分。 非传染性疾病(NCD) 每年造成的死亡人数最多，为1,790 万人，其次是心血管疾病（930 万人）、慢性呼吸道疾病（410 万人）和糖尿病（120 万人）（200 万人，其中包括肾病死亡） 。 这可能是未来几年市场成长的驱动力。

技术进步正在推动新型、更有效率的超级崩解剂的开发。 例如，最近的研究调查了香蕉粉作为过量崩解剂在各种药物製剂（包括片剂和胶囊）中的使用。 这导致这些赋形剂在多种药品配方中的使用增加。 仿製药的需求量很大，因为它们价格实惠且容易获得。

超级崩解剂在製药业中的使用不断增加，以及新的创新解决方案的专利申请数量不断增加，正在推动超级崩解剂市场的成长。 根据美国国家标准技术研究院（NIST）和联合国专利商标局（USPTO）的综合数据，N-乙烯基□咯烷酮+淀粉羟乙酸钠有15项专利，其次是直链淀粉14项。 随着製药商寻求开发更有效率、更有效的药物输送系统，这一趋势预计将持续下去。

超级崩解剂市场报告亮点

由于对快速溶解剂型的需求不断增加，交聚维酮领域预计将会成长。

片剂是製药业最常用的剂型，由于超级崩解剂是片剂配方的关键成分，因此片剂产业呈现出最高的成长率。

由于胃肠道疾病盛行率不断增加以及对以患者为中心的药物输送的日益关注，预计胃肠道疾病将呈现显着增长。

由于慢性病盛行率显着增加和技术进步，预计北美将占据最大的销售份额。

由于中国和印度等发展中国家製药业的成长，预计亚太地区未来几年将呈现强劲的成长速度。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章全球超级崩解剂市场洞察

  • 超级崩解剂市场 - 治疗领域概况
  • 超级崩解剂市场动态
    • 推动者和机会
      • 口腔崩解片越来越受欢迎
      • 不断成长的仿製药市场
    • 抑制因素和挑战
      • 安全性和品质问题
  • PESTEL 分析
  • 超级崩解剂市场治疗领域的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球超级崩解剂市场（按产品）

  • 主要发现
  • 简介
  • 加工淀粉
  • 改性纤维素
  • 交聚维酮
  • 离子交换树脂

第六章全球超级崩解剂市场，以剂型

  • 主要发现
  • 简介
  • 平板电脑
  • 胶囊

第 7 章全球超级崩解剂市场，依治疗领域划分

  • 主要发现
  • 简介
  • 消化系统疾病
  • 神经系统疾病
  • 肿瘤学
  • 传染病
  • 心血管疾病
  • 血液疾病
  • 发炎性疾病

第 8 章全球超级崩解剂市场（按地区）

  • 主要发现
  • 简介
    • 超级崩解剂市场评估，地区，2019-2032 年
  • 超崩解剂市场 - 北美
    • 北美：超级崩解剂市场（按产品），2019-2032 年
    • 北美：超级崩解剂市场，依治疗领域划分，2019-2032 年
    • 北美：超级崩解剂市场（按剂型），2019-2032 年
    • 超崩解剂市场 - 美国
    • 超级崩解剂市场 - 加拿大
  • 超级崩解剂市场 - 欧洲
    • 欧洲：超级崩解剂市场（按产品），2019-2032 年
    • 欧洲：超级崩解剂市场，依治疗领域划分，2019-2032 年
    • 欧洲：超级崩解剂市场（按剂型），2019-2032 年
    • 超级崩解剂市场 - 英国
    • 超崩解剂市场 - 法国
    • 超崩解剂市场 - 德国
    • 超崩解剂市场 - 义大利
    • 超级崩解剂市场 - 西班牙
    • 超崩解剂市场 - 荷兰
    • 超级崩解剂市场 - 俄罗斯
  • 超级崩解剂市场 - 亚太地区
    • 亚太地区：超级崩解剂市场（按产品），2019-2032 年
    • 亚太地区：超级崩解剂市场，依治疗领域划分，2019-2032 年
    • 亚太地区：超级崩解剂市场，按剂型，2019-2032 年
    • 超崩解剂市场 - 中国
    • 超级崩解剂市场 - 印度
    • 超崩解剂市场 - 马来西亚
    • 超崩解剂市场 - 日本
    • 超级崩解剂市场 - 印度尼西亚
    • 超崩解剂市场 - 韩国
  • 超级崩解剂市场 - 中东和非洲
    • 中东和非洲：超级崩解剂市场（按产品），2019-2032 年
    • 中东与非洲：超级崩解剂市场，依治疗领域划分，2019-2032 年
    • 中东和非洲：超级崩解剂市场，按剂型，2019-2032 年
    • 超崩解剂市场 - 沙乌地阿拉伯
    • 超级崩解剂市场 - 阿拉伯联合大公国
    • 超崩解剂市场 - 以色列
    • 超崩解剂市场 - 南非
  • 超级崩解剂市场 - 拉丁美洲
    • 拉丁美洲：超级崩解剂市场（按产品），2019-2032 年
    • 拉丁美洲：超级崩解剂市场，依治疗领域划分，2019-2032 年
    • 拉丁美洲：超级崩解剂市场（按剂型），2019-2032 年
    • 超崩解剂市场 - 墨西哥
    • 超级崩解剂市场 - 巴西
    • 超崩解剂市场 - 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • BASF
  • Roquette Freres
  • Ashland Global
  • Dow DuPont
  • DFE Pharma
  • Asahi Kasei
  • Merck
  • Corel Pharma & Avantor Performance.
Product Code: PM3382

The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report "Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.

Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.

The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.

Superdisintegrants Market Report Highlights

Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.

Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.

Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.

North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.

APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.

The global players include: BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.

Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:

Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified Starch
  • Modified Cellulose
  • Crospovidone
  • Ion Exchange Resin

Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)

  • Tablets
  • Capsules

Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastrointestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Superdisintegrants Market Insights

  • 4.1. Superdisintegrants Market - Therapeutic Area Snapshot
  • 4.2. Superdisintegrants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Adoption of Orally Disintegrating Tablets
      • 4.2.1.2. Growing Generics Market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Safety and Quality Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Superdisintegrants Market Therapeutic Area Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Superdisintegrants Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • 5.3. Modified Starch
    • 5.3.1. Global Superdisintegrants Market, by Modified Starch, by Region, 2019-2032 (USD Million)
  • 5.4. Modified Cellulose
    • 5.4.1. Global Superdisintegrants Market, by Modified Cellulose, by Region, 2019-2032 (USD Million)
  • 5.5. Crospovidone
    • 5.5.1. Global Superdisintegrants Market, by Crospovidone, by Region, 2019-2032 (USD Million)
  • 5.6. Ion Exchange Resin
    • 5.6.1. Global Superdisintegrants Market, by Ion Exchange Resin, by Region, 2019-2032 (USD Million)

6. Global Superdisintegrants Market, by Formulation

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 6.3. Tablets
    • 6.3.1. Global Superdisintegrants Market, by Tablets by Region, 2019-2032 (USD Million)
  • 6.4. Capsules
    • 6.4.1. Global Superdisintegrants Market, by Capsules, by Region, 2019-2032 (USD Million)

7. Global Superdisintegrants Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • 7.3. Gastrointestinal Diseases
    • 7.3.1. Global Superdisintegrants Market, by Gastrointestinal Diseases, By Region, 2019-2032 (USD Million)
  • 7.4. Neurological Diseases
    • 7.4.1. Global Superdisintegrants Market, by Neurological Diseases, By Region, 2019-2032 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Superdisintegrants Market, by Oncology, By Region, 2019-2032 (USD Million)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Superdisintegrants Market, by Infectious Diseases, By Region, 2019-2032 (USD Million)
  • 7.7. Cardiovascular Diseases
    • 7.7.1. Global Superdisintegrants Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Million)
  • 7.8. Hematological Diseases
    • 7.8.1. Global Superdisintegrants Market, by Hematological Diseases, By Region, 2019-2032 (USD Million)
  • 7.9. Inflammatory Diseases
    • 7.9.1. Global Superdisintegrants Market, by Inflammatory Diseases, By Region, 2019-2032 (USD Million)

8. Global Superdisintegrants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Superdisintegrants Market - North America
    • 8.3.1. North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.3.3. North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.4. Superdisintegrants Market - U.S.
      • 8.3.4.1. U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.5. Superdisintegrants Market - Canada
      • 8.3.5.1. Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.4. Superdisintegrants Market - Europe
    • 8.4.1. Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.4.3. Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.4. Superdisintegrants Market - UK
      • 8.4.4.1. UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.5. Superdisintegrants Market - France
      • 8.4.5.1. France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.5.3. France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.6. Superdisintegrants Market - Germany
      • 8.4.6.1. Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.7. Superdisintegrants Market - Italy
      • 8.4.7.1. Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.8. Superdisintegrants Market - Spain
      • 8.4.8.1. Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.9. Superdisintegrants Market - Netherlands
      • 8.4.9.1. Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.10. Superdisintegrants Market - Russia
      • 8.4.10.1. Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.5. Superdisintegrants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.4. Superdisintegrants Market - China
      • 8.5.4.1. China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.4.3. China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.5. Superdisintegrants Market - India
      • 8.5.5.1. India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.5.3. India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.6. Superdisintegrants Market - Malaysia
      • 8.5.6.1. Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.7. Superdisintegrants Market - Japan
      • 8.5.7.1. Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.8. Superdisintegrants Market - Indonesia
      • 8.5.8.1. Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.9. Superdisintegrants Market - South Korea
      • 8.5.9.1. South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.6. Superdisintegrants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.4. Superdisintegrants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.5. Superdisintegrants Market - UAE
      • 8.6.5.1. UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.6. Superdisintegrants Market - Israel
      • 8.6.6.1. Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.7. Superdisintegrants Market - South Africa
      • 8.6.7.1. South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.7. Superdisintegrants Market - Latin America
    • 8.7.1. Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.4. Superdisintegrants Market - Mexico
      • 8.7.4.1. Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.5. Superdisintegrants Market - Brazil
      • 8.7.5.1. Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.6. Superdisintegrants Market - Argentina
      • 8.7.6.1. Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BASF
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Roquette Freres
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Ashland Global
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dow DuPont
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DFE Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Asahi Kasei
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Corel Pharma & Avantor Performance.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development

List of Tables

  • Table 1 Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 3 Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 4 Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 7 North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 8 U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 10 U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 11 Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 13 Canada: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 14 Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 16 Europe: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 17 UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 19 UK: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 20 France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 22 France: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 23 Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 25 Germany: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 26 Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 28 Italy: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 29 Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 31 Spain: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 32 Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 34 Netherlands: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 35 Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 37 Russia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 41 China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 43 China: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 44 India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 46 India: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 47 Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 49 Malaysia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 50 Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 52 Japan: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 53 Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 55 Indonesia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 56 South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 58 South Korea: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 65 UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 67 UAE: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 68 Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 70 Israel: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 71 South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 73 South Africa: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 74 Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 76 Latin America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 77 Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 79 Mexico: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 80 Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 82 Brazil: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 83 Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 85 Argentina: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Superdisintegrants Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Formulation
  • Figure 7. Global Superdisintegrants Market, by Formulation, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Superdisintegrants Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global Superdisintegrants Market, by Therapeutic Area, 2022 & 2032 (USD Million)
  • Figure 12. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Superdisintegrants Market